Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Morning Bell 29 July

Paulina Peters
July 29, 2021

Morning Bell 28 July

Jessica Amir
July 28, 2021

Morning Bell 27 July

Jessica Amir
July 27, 2021

Morning Bell 26 July

Jessica Amir
July 26, 2021

Weekly Wrap 23 July

Jessica Amir
July 23, 2021

Morning Bell 23 July

Jessica Amir
July 23, 2021

Morning Bell 22 July

Jessica Amir
July 22, 2021

Morning Bell 21 July

Sophia Mavridis
July 21, 2021

Morning Bell 20 July

Paulina Peters
July 20, 2021

Morning Bell 19 July

Jessica Amir
July 19, 2021

Weekly Wrap 16 July

Jessica Amir
July 16, 2021